Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zippia finds jobs where you're a top candidate and applies on your behalf.
Shockwave Medical's peak revenue was $730.2M in 2023. The peak quarterly revenue was $218.8M in 2024(q1).
Shockwave Medical's revenue increased from $12.3m in 2018 to $730.2M currently. That's a 5,854.74% change in annual revenue.
| Fiscal year / year | Shockwave Medical revenue |
|---|---|
| 2018 | $12.3M |
| 2019 | $42.9M |
| 2020 | $67.8M |
| 2021 | $237.1M |
| 2022 | $489.7M |
| 2023 | $730.2M |
How accurately did Shockwave Medical's revenue projections match actual performance?
Shockwave Medical saw the greatest revenue growth in 2019, when revenue increased by 250.05%.
Shockwave Medical had the lowest revenue growth in 2020, when revenue changed by 57.92%.
| Year | Shockwave Medical growth |
|---|---|
| 2019 | 250%↑ |
| 2020 | 58%↑ |
| 2021 | 250%↑ |
| 2022 | 107%↑ |
| 2023 | 49%↑ |
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | - | $5.1M |
| 2019 | $7.3M | $10.0M | $11.3M | $14.3M |
| 2020 | $15.2M | $10.3M | $19.6M | $22.7M |
| 2021 | $31.9M | $55.9M | $65.2M | $84.2M |
| 2022 | $93.6M | $120.7M | $131.3M | $144.0M |
| 2023 | $161.1M | $180.2M | $186.0M | $203.0M |
| 2024 | $218.8M | - | - | - |
Do you work at Shockwave Medical?
Is Shockwave Medical transparent about its revenue structure?
| CEO | Douglas Evan Godshall |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 657 |
| Date Founded | 2009 |
| Headquarters | Fremont, California |
| Number of Locations | 1 |
| Revenue | $730.2M |
| Net Income | $215,996,000 |
| Gross Proft | $634.8M (2023) |
| Tax Rate | 0.2% |
| Total Assets | $646,089,000 |
| Ticker | SWAV |
Shockwave Medical received early financing of $12.5M on 2014-01-27.
| Series | Round size | Date |
|---|---|---|
| Series A | $12.5M | 01/2014 |
| Series B | $40M | 05/2015 |
| Series C | $45M | 11/2016 |
| Series C | $35M | 10/2017 |
| Series D | $15M | 12/2018 |
| Investors | Security type |
|---|---|
| SOFINNOVA PARTNERS | Series A |
| Ally Bridge Group | Series B |
| Sectoral Asset Management | Series B |
| Deerfield | Series B |
| Venrock | Series B |
| RA Capital Management | Series B |
| SOFINNOVA PARTNERS | Series B |
| Ally Bridge Group | Series C |
| Sectoral Asset Management | Series C |
| Venrock | Series C |
| Deerfield | Series C |
| T. Rowe Price Group, Inc. | Series C |
| RA Capital Management | Series C |
| SOFINNOVA PARTNERS | Series C |
| T. Rowe Price Group, Inc. | Series C |
| Fidelity Management & Research Co LLC | Series C |
| Abiomed, Inc. | Series D |
| Venrock | Series D |
| T. Rowe Price Group, Inc. | Series D |
| SOFINNOVA PARTNERS | Series D |
Zippia gives an in-depth look into the details of Shockwave Medical, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Shockwave Medical. The employee data is based on information from people who have self-reported their past or current employments at Shockwave Medical. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Shockwave Medical. The data presented on this page does not represent the view of Shockwave Medical and its employees or that of Zippia.
Shockwave Medical may also be known as or be related to SHOCKWAVE MEDICAL, INC., Shockwave Medical, Shockwave Medical Inc, Shockwave Medical Inc. and Shockwave Medical, Inc.